[Cochrane reviews compared with industry-supported and other meta-analyses of the same drugs--secondary publication]
- PMID: 17147949
[Cochrane reviews compared with industry-supported and other meta-analyses of the same drugs--secondary publication]
Abstract
24 Cochrane reviews were compared with other, closely matched, meta-analyses of the same drugs. The quality score was highest for Cochrane reviews (7 vs. 2, p < 0.01). Of 8 industry-supported reviews, 7 with conclusions all recommended the experimental drug without reservations, compared with none of the Cochrane reviews (p = 0.02) although the estimated treatment effect was similar on average (p = 0.64). Industry-supported reviews were less transparent, had few reservations about methodological limitations of the included trials, and should be read with caution.
Republished from
-
Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review.BMJ. 2006 Oct 14;333(7572):782. doi: 10.1136/bmj.38973.444699.0B. Epub 2006 Oct 6. BMJ. 2006. PMID: 17028106 Free PMC article.